Thorsten Melcher Ph.D., CBO at RefleXion, and Dr. Giovanni Selvaggi, CEO and CMO at Xcovery, discuss advances in two key areas that could mean a longer life for more Stage 4 patients. The watchwords are customization and personalization. The finding that the customized pairing of two therapies, used in combination, versus in a sequence, creates a synergistic effect, is coupled with the realization every patient's cancer is personalized to their unique system. Developing a plan that includes a patient assessment, multiple treatment options, and how best to combine them, is a promising new direction.
Speakers:
Thorsten Melcher Ph.D. - CBO, RefleXion
Giovanni Selvaggi, M.D. - CEO & CMO, Xcovery
For more information, please visit https://reflexion.com
04/27/21 • 24 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/reflexion-podcast-329774/one-two-punch-to-cancer-48122297"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to one-two punch to cancer on goodpods" style="width: 225px" /> </a>
Copy